Current Advances in Epidemiology, Diagnosis, and Management of TAVR-Associated Infective Endocarditis: A Narrative Review.

Zhenzhen Li, Dawei Lin, Jianing Fan, Jiaxin Miao, Wenzhi Pan, Daxin Zhou

Abstract readReview

In one paragraph

Review in Reviews in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Changing Patterns in Infective Endocarditis: A Contemporary Epidemiological Perspective.Pathogens (Basel, Switzerland) · 2026
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhenzhen LiSchool of Health Science and Engineering, University of Shanghai for Science and Technology, 200093 Shanghai, China.ORCID https://orcid.org/0009-0003-1080-2963

Dawei LinDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 200032 Shanghai, China.ORCID https://orcid.org/0009-0006-5870-7780

Jianing FanDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 200032 Shanghai, China.ORCID https://orcid.org/0000-0002-1952-2701

Jiaxin MiaoDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 200032 Shanghai, China.ORCID https://orcid.org/0009-0006-1807-8588

Wenzhi PanSchool of Health Science and Engineering, University of Shanghai for Science and Technology, 200093 Shanghai, China.ORCID https://orcid.org/0000-0002-0530-261X

Daxin ZhouSchool of Health Science and Engineering, University of Shanghai for Science and Technology, 200093 Shanghai, China.ORCID https://orcid.org/0009-0007-9814-3630

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With ongoing technological advancements and device innovations, transcatheter aortic valve replacement (TAVR) has become a well-established therapeutic approach for managing aortic stenosis and regurgitation. As indications for TAVR expand, particularly into younger patient populations, the incidence of TAVR-associated infective endocarditis (TAVR-IE) has concurrently increased. Although the reported incidence of TAVR-IE remains relatively low (0.3%-2.0% per 100 patient-years), its clinical outcomes are notably poor, with mortality rates considerably higher than those observed in general infective endocarditis (IE). Moreover, the microbiological profile of TAVR-IE differs distinctly from surgical aortic valve replacement-associated IE (SAVR-IE), predominantly involving

Indexed as

antibiotic prophylaxisclinical outcomesdiagnosisepidemiologyinfective endocarditismicrobiologyrisk factorsTAVR-IEtranscatheter aortic valve replacement

Identifiers

PMID41659087

DOI10.31083/RCM44599

PMCPMC12873667

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.